A comparison was made of the in vitro activity of ciprofloxacin (Bay o 9867) with nine other antibiotics against isolates of Campylobacterjejuni, Salmonella spp., Shigella spp., Yersinia enterocolitica, Clostridium difficile, Vibrio spp., and Escherichia coli. Minimum inhibitory concentrations of ciprofloxacin were the lowest of any compound tested for all organisms except C. difficile.
considerable activity against bacterial enteric patho,gens in vitro (6), we decided to evaluate the activity of ciprofloxacin and compare it with nine other antimicrobial agents which may be useful for treatment of infections caused by these pathogens.
Susceptibility testing was performed by using MuellerHinton agar and standard agar dilution methods (4, 5) , except for Campylobacterjejuni and Clostridium difficile for which Wilkins-Chalgren agar was used. Inocula were prepared by transferring three to five colonies'from an overnight culture of the organism into Trypticase soy broth. After 2 to 4 h of growth, the turbidity was adjusted to a 0.5' McFarland turbidity standard with sterile saline. For'C. difficile and C. jejuni, three to five colonies from a 48-h growth were inoculated into Wilkins-Chalgren broth and incubated overnight. The (2) . The following control stains were used: Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922, Bacteroidesfragilis ATCC 25285, and Bacteroides thetaiotaomicron ATCC 29741. 'All organisms were stored at -70°C and were subcultured at least twice on appropriate media before susceptibility testing.
Compounds used in this study were 'obtained from the following sources: ciprofloxacin, Miles Pharmaceuticals. Thymidine phosphorylase (0.1 U/ml; Burroughs Wellcome) was added to all plates when testing trimethoprimsulfamethoxazole. In our study, ciprofloxacin was more active against bacterial enteric pathogens than nalidixic acid or norfloxacin. We confirmed the general lack of activity of nalidixic acid and norfloxacin against C. difficile. Although ciprofloxacin was more active than these two agents against this anaerobe, it was much less active than vancomycin or erythromycin. Although numbers of organisms were small, ciprofloxacin showed good activity against Salmonella spp. which were resistant to either doxycycline, ampicillin, or chloramphenicol and Shigella spp. isolates resistant to either ampicillin, doxycycline, or erythromycin.
Our findings are in agreement with the results of Shungu et al. (6) , Carlson et al. (1) and others (7) who demonstrated the in vitro activity of several of the quinolone derivatives against common bacterial enteric pathogens. Clinical studies should be undertaken to evaluate the effectiveness of these drugs in the treatment of diarrheal illnesses.
